Avoid These 3 Downgraded Stocks Like the Plague By StockNews

© Reuters. Avoid These 3 Downgraded Stocks Like the Plague

With volatility still prevalent in the market, it always a good idea for investors to avoid the worst stocks. Our proprietary POWR Ratings system evaluates stocks based on 118 different factors. Stocks with Strong Sell ratings typically underperform the market. ENGlobal Corporation (ENG), Kopin Corporation (KOPN), and Velodyne Lidar (VLDR) are three recently downgraded stocks that investors should avoid.Sort through the latest POWR Ratings updates, and you will find there is considerable movement in both directions. Plenty of stocks have been upgraded and downgraded this past week.

But this article will focus on stocks that you should avoid. Even as the market hits new highs, uncertainty remains with COVID-19 cases rising. That’s why it’s just as important to avoid bad stocks as it is to buy the best stocks.

Below, I provide a quick look at three of the latest downgrades in ENGlobal Corporation (ENG), Kopin Corporation (KOPN), and Velodyne Lidar (VLDR).

Continue reading on StockNews

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*